Pulmonary Fibrosis News

Home
United States
Dallas, TX
Pulmonary Fibrosis News

We are dedicated to sharing the latest news, research, and pulmonary fibrosis patient perspectives.

12/24/2025

Columnist Samuel Kirton talks with the Pulmonary Fibrosis Foundation's Amy Hajari Case, MD, about the Accelerate Research initiative. https://buff.ly/R5IvrUQ

12/23/2025

Winning its second FDA approval this year, Boehringer Ingelheim's oral drug Jascayd is now cleared for use in the U.S. by adults with PPF. https://buff.ly/jpbRWT9

12/19/2025

In most cases, the exact cause of the lung scarring associated with PF is never determined. https://bit.ly/3MMjCsu

Rarely, PF can run in families and have a genetic basis.

PF also may develop in association with other diseases, especially autoimmune disorders like rheumatoid arthritis and scleroderma.

Furthermore, lung scarring can be caused by certain infections or exposure to toxic substances in the air.

Explore what we currently know about the causes of PF here: https://bit.ly/3MMjCsu

12/17/2025

GRI-0621, an experimental oral therapy from GRI Bio, boosts lung function in adults with IPF, according to top-line clinical trial data. https://buff.ly/MQkGwoq

12/17/2025

Columnist Sam Kirton has wonderful memories of holiday presents, but the greatest gift he's received came in the form of a lung transplant. https://buff.ly/zm46Ccl

12/16/2025

Caring for someone you love is intimate, humbling, and grounding, writes columnist Ann Reynoso, who swapped caregiver roles with her husband. https://buff.ly/5msbkhj

12/10/2025

Building on positive Phase 2 data, Puretech plans to launch a Phase 3 trial to further evaluate its experimental IPF therapy deupirfenidone. https://buff.ly/D5oqKzW

12/09/2025

Remembering loved ones who have passed invites waves of grief, but for columnist Sam Kirton, there is also joy to be found in the memories. https://buff.ly/8CkaHsh

12/08/2025

Less than a year after her husband was diagnosed with PF, Kylene and her family decided to take a road trip. https://bit.ly/3M8SCmB

A year earlier, travel had been entirely out of the picture, and this trip represented a massive milestone.

Ultimately, it turned out to be just the reminder they needed that life doesn’t end with a diagnosis.

Read why here: https://bit.ly/3M8SCmB

12/03/2025

The FDA has granted orphan drug designation to Birchbiomed’s FS2 as a treatment for idiopathic pulmonary fibrosis, or IPF. https://buff.ly/4ZMie3C

Address

Dallas, TX

Telephone

+12143797441

Website

http://pulmonaryfibrosisnews.com/

Alerts

Be the first to know and let us send you an email when Pulmonary Fibrosis News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.